(Q33193490)

23 July 2017

title

Human rhinovirus capsid dynamics is controlled by canyon flexibility (English)

1 reference

23 July 2017

Thomas J Smith

7

0 references

Gary Siuzdak

object named as

Gary Siuzdak

6

0 references

author name string

Nichole Reisdorph

1

1 reference

23 July 2017

John J Thomas

2

1 reference

23 July 2017

Umesh Katpally

3

1 reference

23 July 2017

Elaine Chase

4

1 reference

23 July 2017

Ken Harris

5

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

23 July 2017

1 reference

23 July 2017

volume

314

1 reference

23 July 2017

issue

1

1 reference

23 July 2017

page(s)

34-44

1 reference

Three-dimensional structures of drug-resistant mutants of human rhinovirus 14

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Crystallographically identical virus capsids display different properties in solution.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Viral capsid mobility: a dynamic conduit for inactivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Structural differences between foot-and-mouth disease and poliomyelitis viruses influence their inactivation by aziridines

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Evidence for the direct involvement of the rhinovirus canyon in receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Preparation of stable isotope-incorporated peptide internal standards for field desorption mass spectrometry quantification of peptides in biologic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Crystallization of a common cold virus, human rhinovirus 14: “Isomorphism” with poliovirus crystals

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Identification and C-terminal characterization of proteins from two-dimensional polyacrylamide gels by a combination of isotopic labeling and nanoelectrospray Fourier transform ion cyclotron resonance mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Antiviral agent blocks breathing of the common cold virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Quantitation of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Structure of a human rhinovirus complexed with its receptor molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

A novel basis of capsid stabilization by antiviral compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Enzymatic preparation of carboxyl oxygen-18 labeled prostaglandin F2α and utility for quantitative mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Pleconaril: a novel antipicornaviral drug

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Structure of a human common cold virus and functional relationship to other picornaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Isotopic distributions in mass spectra of large molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

Evidence for at least two dominant neutralization antigens on human rhinovirus 14.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

WIN 52035-dependent human rhinovirus 16: assembly deficiency caused by mutations near the canyon surface.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900452-5

7 January 2021

10.1016/S0042-6822(03)00452-5

Identifiers

DOI

1 reference

23 July 2017

1 reference